Microscopy analysis of tumor sections, as well as in vitro and in vivo experiments with anti-HGF agents, have suggested that both autocrine and paracrine signaling of HGF occurs in gliomas (90, 91, 93, 95–97). This evidence concerns the gene HGF and central nervous system cancer.